Abstract
4/2020
vol. 95
Review paper
Use of the Brief Observation of Symptoms of Autism (BOSA) as a new clinical approach to assessing patients with suspected spectrum disorder during the COVID-19 pandemic
- Department of Psychiatry, Institute of Medical Sciences, Medical College of Rzeszów University, Poland
- Kennedy Krieger Institute, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, USA
- Department of Developmental Psychiatry, Psychotic and Geriatric Disorders, Medical University of Gdańsk, Poland
- Department of Paediatrics, Institute of Medical Sciences, Medical College of Rzeszów University, Poland
Online publish date: 2021/01/30
COVID-19 has imposed major changes to the delivery of healthcare worldwide. In many settings, healthcare is now predominantly transitioned to telehealth, creating challenges and unique benefits. In 2020, the Centers for Disease Control and Prevention has reported that 1 in 54 children in the U.S. are diagnosed with autism spectrum disorder (ASD). The Brief Observation of Symptoms of Autism (BOSA) is a new clinical approach that has been developed to ensure that patients suspected of ASD can receive valid diagnostic assessments during the pandemic. BOSA is offered when a diagnostician is unable to administer the Autism Diagnostic Observation Schedule – Second Edition (ADOS-2) either because it is not appropriate to administer the ADOS-2 via telehealth or, in person, face coverings confound ASD assessment. Only trained ADOS-2 diagnosticians can administer BOSA, because BOSA relies on ADOS-2 codes. The article describes BOSA to prepare the field for future research during the COVID-19 crisis.
Keywords
COVID-19 pandemic, BOSA, ADOS-2, autism spectrum disorder
Integrated with
Editorial Policies
